[1]袁航,章斌,邓胜明,等.淋巴瘤细胞株Raji摄取18F-氟脱氧葡萄糖和18F-氟脱氧胸腺嘧啶核苷的体外实验研究[J].国际放射医学核医学杂志,2009,33(6):327-330.[doi:10.3760/cma.j.issn.1673-4114.2009.06.002]
　YUAN Hang,ZHANG Bin,DENG Sheng-ming,et al.In vitro study of uptaking 18F-fluorodeoxyglucose and 18-fluorodeoxythymidine in human lymphoma Raji cell[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):327-330.[doi:10.3760/cma.j.issn.1673-4114.2009.06.002]
点击复制

淋巴瘤细胞株Raji摄取18F-氟脱氧葡萄糖和18F-氟脱氧胸腺嘧啶核苷的体外实验研究(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
33
期数:
2009年第6期
页码:
327-330
栏目:
实验核医学
出版日期:
1900-01-01

文章信息/Info

Title:
In vitro study of uptaking 18F-fluorodeoxyglucose and 18-fluorodeoxythymidine in human lymphoma Raji cell
作者:
袁航;  章斌;  邓胜明;  吴翼伟
苏州大学附属第一医院核医学科, 苏州 215006
Author(s):
YUAN Hang;  ZHANG Bin;  DENG Sheng-ming;  WU Yi-wei
Department of Nuclear Medwine, The First Affiliated Hospital of Soochow University, Suzhou 215006, China
关键词:
淋巴瘤; 氟脱氧葡糖F18; 胸腺嘧啶核苷酸类; 细胞结合率
Keywords:
Lymphoma; Fluorodeoxyglucose; Thymine nucleotides; Cell conjugation rate
DOI:
10.3760/cma.j.issn.1673-4114.2009.06.002
摘要:
目的 研究测定人淋巴瘤细胞株Raji摄取18F-氟脱氧葡萄糖(18F-FDG)和18F-氟脱氧胸腺嘧啶核苷(18F-FLT)的方法并比较两者的差异。方法 在不同条件下测定淋巴瘤细胞株Raji对18F-FDG和18F-FLT的细胞结合率:细胞数量1×105~1×107/瓶;18F-FDG和18F-FLT的放射性活度1.85~29.6 kBq;反应时间20~120min;葡萄糖浓度0~11.1mmol/L。结果 每瓶1×107个细胞、加入3.7 kBq 18F-FDG、葡萄糖浓度在0~2.78 mmol/L、作用100min,18F-FDG细胞结合率达到(50.42±1.07)%;每瓶1×107个细胞、加入3.7 kBq 18F-FLT、作用100min,18F-FLT细胞结合率达到(59.48±0.77)%;18F-FDG和18F-FLT的细胞结合率之间具有统计学差异(F=1192.805,P<0.001)。结论 Raji细胞与18F-FDG的结合率与细胞数量、作用时间及葡萄糖浓度有关,与18F-FDG的放射性活度无关;Raji细胞与18F-FLT的结合率与细胞数量和作用时间有关,与18F-FLT的放射性活度及葡萄糖浓度无关;同等条件下,Raji细胞对18F-FLT的细胞结合率高于18F-FDG。
Abstract:
Objective To investigate the binding characteristics of 18F-fluorodeoxyglucose(18F-FDG) and 18F-fluorodeoxythymidine(18F-FLT) with human lymphoma cell Raji and the differences between them.Methods The binding rates of 18F-FDG and 18F-FLT was measured under different conditions:1×105~107 cells,1.85~29.6 kBq 18F-FDG or 18F-FLT, 0~11.1 mmol/L glucose levels and 20~120 min to measure.Results The binding rate of 18F-FDG was(50.42±1.07) % at the condition of l×107 cells, 3.7 kBq 18F-FDG,0~2.78 mmol/L glucose levels, 100 min, while 18F-FLT was(59.48 ±0.77) % at the same conditions. The difference of binding rates between 18F-FDG and 18F-FLT was significant(F=1192.805, P<0.001).Conclusion The uptake of 18F-FDG and 18F-FLT in human lymphoma Raji cell is high, and at the same condition, the uptake rate of 18F-FLT is higher than 18F-FDG.

参考文献/References:

[1] Ell PJ.The contribution of PET/CT to improved patient management.Br J Radiol,2006,79(1):32-36.
[2] von Schulthess GK,Steinert HC,Hany TF.Integrated PET/CT:Current applications and future directions.Radiology,2006,238(2):405-422.
[3] Warburg O,Wind F,Negalein E.The metabolism of tumours in the body.J Gen Physiol,1927,8(6):519-530.
[4] Shields AF.Positron emission tomography measurement of tumor metabolism and growth:its expanding role in oncology.Mol Imaging Biol,2006,8(3):141-150.
[5] Del Rocío Estrada-Sánchez G,Altamirano-Ley J,Ochoa-Carrillo FJ.Normal variants and frequent pitfalls with (18)FDG PET/CT study.Cir Cir,2007,75(6):491-497.
[6] Been LB,Suurmeijer AJ,Cobben DC,et al.[18F]-FLT-PET in oncology:current status and opportunities.Eur J Nucl Med Mol Imaging,2004,31(12):1659-1672.
[7] 张平安,邹力,何其敏,等.血清胸腺嘧啶核苷激酶的检测及临床意义.临床检验杂志,2000,18(4):199-201.
[8] Wagner M,Seitz U,Buck A,et al.3’-[18F]fluoro-3’-deoxythymi-dine([18F]-FLT)as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.Cancer Res,2003,63(10):2681-2687.

相似文献/References:

[1]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
　Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[2]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
　You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[3]胡娜,吴永港,肖立志,等.18F-FDG PET/CT代谢活性参数及其在淋巴瘤中的应用[J].国际放射医学核医学杂志,2015,39(4):342.[doi:10.3760/cma.j.issn.1673-4114.2015.04.015]
　Hu Na,Wu Yonggang,Xiao Lizhi,et al.Metabolic parameters of 18F-FDG PET/CT and their application in lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):342.[doi:10.3760/cma.j.issn.1673-4114.2015.04.015]
[4]戴娜,吴翼伟.影像学技术在霍奇金淋巴瘤诊疗中的价值[J].国际放射医学核医学杂志,2014,38(2):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
　Dai Na,Wu Yiwei.The value of medical imaging methods in diagnosis and treatment of Hodgkin lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):117.[doi:10.3760/cma.j.issn.1673-4114.2014.02.011]
[5]杨希,党春江.泌尿系统原发性结外淋巴瘤的临床及影像学表现[J].国际放射医学核医学杂志,2013,37(4):230.[doi:10.3760/cma.j.issn.1673-4114.2013.04.010]
　YANG Xi,DANG Chun-jiang.The clinical and imaging appearances of primary extranodal lymphoma of the urinary system[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):230.[doi:10.3760/cma.j.issn.1673-4114.2013.04.010]
[6]李艳梅,杨建伟,李鹏,等.单眼虹膜原发非霍奇金淋巴瘤18F-FDGPET/CT显像及疗效评价一例[J].国际放射医学核医学杂志,2013,37(5):326.[doi:10.3760/cma.j.issn.1673-4114.2013.05.017]
[7]萨日,赵红光,关锋,等.18F-FDG PET/CT在弥漫性大B细胞淋巴瘤疗效评价中的临床价值[J].国际放射医学核医学杂志,2013,37(1):9.[doi:10.3760/cma.j.issn.1673-4114.2013.01.003]
　SA Ri,ZHAO Hong-guang,GUAN Feng,et al.Clinical value of 18F-FDG PET/CT in evaluation of curative effect on diffuse large B cell lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):9.[doi:10.3760/cma.j.issn.1673-4114.2013.01.003]
[8]王月英,吴红英,李德冠,等.小鼠不同肿瘤模型对放化疗敏感性的研究[J].国际放射医学核医学杂志,2012,36(5):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
　WANG Yue-ying,WU Hong-ying,LI De-guan,et al.The radiation sensitivities of different mice tumor model to radiotherapy and chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(6):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
[9]李倩,刘建军.18F-FDG PET-CT评价淋巴瘤疗效及预后的价值[J].国际放射医学核医学杂志,2011,35(4):220.[doi:10.3760/cma.j.issn.1673-4114.2011.04.006]
　LI Qian,LIU Jian-jun.The value of 18F-FDG PET-CT in lymphoma therapy evaluation and prognosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):220.[doi:10.3760/cma.j.issn.1673-4114.2011.04.006]
[10]崔玥婵,朱晓琳,张雪君.超声引导下穿刺活检术对颈部淋巴结诊断的现状及进展[J].国际放射医学核医学杂志,2011,35(6):369.[doi:10.3760,cma.j.issn.1673-4114.2011.06.013]
　CUI Yue-chaan,ZHU Xiao-lin,ZHANG Xue-jun.Status and advances of cervical lymph nodes diagnosis by ultrasound-guided core-needle biopsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):369.[doi:10.3760,cma.j.issn.1673-4114.2011.06.013]

备注/Memo

备注/Memo:
收稿日期:2009-08-05。
通讯作者:吴翼伟(E-mail:wuyiwei8938@gmail.com)
更新日期/Last Update: 1900-01-01